lexiara

—

the patients participating in the trial have the same characteristics as those covered by the indication specified in the abovementioned authorisation.

· All articles ·

Source: EUR-Lex (Cellar) · retrieved 2026-11-03 · Text as adopted (Official Journal); later amendments are not incorporated in this text.